Skip to main content

Table 3 Summary of the microbiological response

From: A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections

 

Ceftriaxone-sulbactam

Cefoperazone-sulbactam

P

Microbiological response on the day after completion of therapy, n(%)

1344

129

0.9347

Eradication

112(83.58)

108(83.72)

 

Partial eradication/no eradication/super infection/re-infection

22(16.42)

21(16.28)

 

Microbiological response for gram-negative germs, n(%)

129

120

0.8361

Eradication

109(85.83)

100(84.13)

 

Partial eradication/no eradication/super infection/re-infection

18(14.17)

20(16.67)

 

Microbiological response for gram-positive germs, n(%)

5

9

0.2269

Eradication

3(60.00)

8(88.89)

 

Partial eradication/no eradication/super infection/re-infection

2(40.00)

1(11.11)

 

Microbiological response for RTIs, n(%)

65

65

1.0000

Eradication

52(80.00)

53(81.54)

 

Partial eradication/no eradication/super infection/re-infection

13(20.00)

12(18.46)

 

Microbiological response for UTIs, n(%)

69

64

1.0000

Eradication

60(86.96)

55(85.94)

 

Partial eradication/no eradication/super infection/re-infection

9(13.04)

9(14.06)

 

Microbiological response at the day 7 follow-up, n(%)

114

103

0.8300

Eradication

80(70.18)

76(73.79)

 

Partial eradication/no eradication/super infection/re-infection

4(3.51)

3(2.91)

 

Assumed eradication(no material for culture)

30(26.32)

24(23.30)

 
  1. RTIs: Respiratory tract infections.
  2. UTIs: Urinary tract infections.